Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis

被引：0
作者：
Xiaoying Sun
Raheleh Roudi
Ting Dai
Shangya Chen
Bin Fan
Hongjin Li
Yaqiong Zhou
Min Zhou
Bo Zhu
Chengqian Yin
Bin Li
Xin Li
机构：
[1] Shanghai University of Traditional Chinese Medicine,Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
[2] Shanghai Academy of Traditional Chinese Medicine,Institute of Dermatology
[3] Iran University of Medical Sciences,Oncopathology Research Center
[4] Shandong Academy of Occupational Health and Occupational Medicine,Department of Toxicology
[5] Shandong Academy of Medical Science,Department of Pharmacology & Experimental Therapeutics
[6] Boston University School of Medicine,Department of Dermatology
[7] Shaanxi Traditional Chinese Medicine Hospital,undefined
来源：
BMC Cancer | / 19卷
关键词：
Non-small cell lung cancer; Oncology; Programmed cell death protein-1; Programmed cell death ligand 1; Inhibitor; Immune-related adverse event; Meta-analysis; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   Immunogenomic correlates of immune-related adverse events for anti-programmed cell death 1 therapy [J].
Zhang, Lei ;
Shi, Yuankai ;
Han, Xiaohong .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[42]   Discrepancy in Programmed Cell Death-Ligand 1 Between Primary and Metastatic Non-small Cell Lung Cancer [J].
Takamori, Shinkichi ;
Toyokawa, Gouji ;
Okamoto, Isamu ;
Takada, Kazuki ;
Kozuma, Yuka ;
Matsubara, Taichi ;
Haratake, Naoki ;
Akamine, Takaki ;
Katsura, Masakazu ;
Mukae, Nobutaka ;
Shoji, Fumihiro ;
Okamoto, Tatsuro ;
Oda, Yoshinao ;
Iwaki, Toru ;
Iihara, Koji ;
Nakanishi, Yoichi ;
Maehara, Yoshihiko .
ANTICANCER RESEARCH, 2017, 37 (08) :4223-4228
[43]   Clinical Significance of Endothelial Programmed Cell Death Ligand 1 Expression in Patients with Non-Small Cell Lung Cancer [J].
Saito, T. ;
Ishida, M. ;
Maru, N. ;
Utsumi, T. ;
Matsui, H. ;
Taniguchi, Y. ;
Hino, H. ;
Murakawa, T. .
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) :S559-S559
[44]   Anti-Programmed Cell Death-1 Versus Anti-Programmed Death-Ligand 1 (PD-L1) in PD-L1-Negative Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis [J].
Al-Showbaki, Laith ;
Al-Kasasbeh, Malak ;
Jbarah, Karem ;
AL-Nusair, Jowan ;
Yamin, Saif ;
Alqaisi, Husam ;
Alrabi, Kamal ;
Amir, Eitan .
WORLD JOURNAL OF ONCOLOGY, 2025, 16 (03) :299-310
[45]   The overall safety evaluation of programmed cell death/programmed cell death ligand 1 (PD-1/PD-L1) treatment for lung cancer patients An updated systematic review and meta-analysis [J].
Shang, Heli ;
Zhang, Zewen ;
Feng, Alei ;
Yang, Xiaowei ;
Zhang, Shuisheng ;
Zhao, Yi ;
Zhu, Qingshan ;
Mao, Yantao ;
Liu, Kun ;
Tian, Yuan .
MEDICINE, 2019, 98 (30)
[46]   Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis [J].
Pan, Zhen-Kui ;
Ye, Feng ;
Wu, Xuan ;
An, Han-Xiang ;
Wu, Jing-Xun .
JOURNAL OF THORACIC DISEASE, 2015, 7 (03) :462-470
[47]   Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature [J].
Tsiogka, Aikaterini ;
Bauer, Johann W. ;
Patsatsi, Aikaterini .
ACTA DERMATO-VENEREOLOGICA, 2021, 101 :1-7
[48]   Association of immune-related pneumonitis with clinical benefit of anti-programmed cell death-1 monotherapy in advanced non-small cell lung cancer [J].
Ono, Kana ;
Ono, Hirotaka ;
Toi, Yukihiro ;
Sugisaka, Jun ;
Aso, Mari ;
Saito, Ryohei ;
Kawana, Sachiko ;
Aiba, Tomoiki ;
Odaka, Tetsuo ;
Matsuda, Suguru ;
Saito, Shin ;
Narumi, Akane ;
Ogasawara, Takahiro ;
Shimizu, Hisashi ;
Domeki, Yutaka ;
Terayama, Keisuke ;
Kawashima, Yosuke ;
Nakamura, Atsushi ;
Yamanda, Shinsuke ;
Kimura, Yuichiro ;
Honda, Yoshihiro ;
Sugawara, Shunichi .
CANCER MEDICINE, 2021, 10 (14) :4796-4804
[49]   Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis [J].
Cai, Huarong ;
Zhang, Haimei ;
Jiang, Yuequan .
FRONTIERS IN ONCOLOGY, 2020, 10
[50]   Rare Adverse Events with Programmed Death-1 and Programmed Death-1 Ligand Inhibitors: Justification and Rationale for a Systematic Review [J].
Smith, Caleb J. ;
Almodallal, Yahya ;
Jatoi, Aminah .
CURRENT ONCOLOGY REPORTS, 2021, 23 (07)
12345